Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Exclusion Criteria

• •Known hypersensitivity or known allergy that would preclude study drug administration
• •Inability to obtain ophthalmic imaging, eg, due to media opacity, inadequate pupillary dilation, allergy to fluorescein dye or lack of venous access
• •Uncontrolled diabetes mellitus
• •History of cerebrovascular accident (CVA) or myocardial infarction within 180 days of the Day 1 visit
• •Renal failure, dialysis, or history of renal transplant
• •Concurrent psychiatric or medical condition that in the opinion of the Investigator will interfere with study participation or completion
• •Pregnant or breastfeeding women